Geneos Wealth Management’s iShares Morningstar Mid-Cap Growth ETF IMCG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$696K Buy
7,076
+2
+0% +$180 0.01% 630
2026
Q1
$557K Buy
7,074
+2
+0% +$164 0.01% 660
2025
Q4
$565K Buy
7,072
+4
+0.1% +$325 0.01% 633
2025
Q3
$585K Sell
7,068
-1,221
-15% -$99.6K 0.01% 611
2025
Q2
$665K Buy
8,289
+1,763
+27% +$131K 0.02% 629
2025
Q1
$466K Buy
6,526
+618
+10% +$47.1K 0.02% 647
2024
Q4
$446K Buy
5,908
+141
+2% +$10.8K 0.02% 622
2024
Q3
$421K Sell
5,767
-54
-0.9% -$3.75K 0.02% 600
2024
Q2
$394K Buy
5,821
+53
+0.9% +$3.6K 0.02% 552
2024
Q1
$408K Buy
5,768
+145
+3% +$9.66K 0.02% 541
2023
Q4
$362K Sell
5,623
-145
-3% -$8.52K 0.02% 538
2023
Q3
$330K Buy
5,768
+85
+1% +$5.13K 0.02% 554
2023
Q2
$346K Buy
5,683
+78
+1% +$4.47K 0.02% 549
2023
Q1
$323K Buy
5,605
+340
+6% +$19.4K 0.02% 537
2022
Q4
$284K Buy
5,265
+4,249
+418% +$229K 0.02% 543
2022
Q3
$51K Sell
1,016
-432
-30% -$24.1K ﹤0.01% 1020
2022
Q2
$76K Sell
1,448
-549
-27% -$31.3K ﹤0.01% 1108
2022
Q1
$128K Buy
1,997
+42
+2% +$2.71K 0.01% 989
2021
Q4
$143K Sell
1,955
-298
-13% -$21.7K 0.01% 1029
2021
Q3
$156K Buy
2,253
+1
+0% +$71 0.01% 966
2021
Q2
$156K Sell
2,252
-11,254
-83% -$742K 0.01% 961
2021
Q1
$149K Buy
13,506
+10,956
+430% +$709K ﹤0.01% 1104
2020
Q4
$160K Hold
2,550
– – 0.01% 917
2020
Q3
$134K Hold
2,550
– – 0.01% 825
2020
Q2
$121K Hold
2,550
– – 0.01% 831
2020
Q1
$91K Buy
2,550
+1,950
+325% +$82.7K 0.01% 867
2019
Q4
$26K Buy
+600
New +$25.2K ﹤0.01% 1576
2016
Q3
– Sell
-456
Closed -$11K – 1979
2016
Q2
$11K Hold
456
– – ﹤0.01% 1293
2016
Q1
$11K Buy
+456
New +$10.8K ﹤0.01% 1277

Other funds holding IMCG

Geneos Wealth Management's IMCG Position: Q2 2026 in Review

Geneos Wealth Management increased its iShares Morningstar Mid-Cap Growth ETF (IMCG) stake by 0.03% in Q2 2026, buying an estimated $180 and bringing the position to 7,076 shares worth $696K. The position accounts for 0.01% of the portfolio, ranked #630.

Geneos Wealth Management first reported a position in IMCG in Q1 2016 and has held it in 29 quarters since. 423 funds tracked by Wall St. Rank hold IMCG as of Q2 2026.

  • Geneos Wealth Management held 7,076 shares of iShares Morningstar Mid-Cap Growth ETF worth $696K as of Q2 2026.
  • Geneos Wealth Management bought 2 iShares Morningstar Mid-Cap Growth ETF shares in Q2 2026, an estimated $180.
  • iShares Morningstar Mid-Cap Growth ETF made up 0.01% of Geneos Wealth Management's portfolio in Q2 2026, its #630 holding.
  • Geneos Wealth Management first reported a position in iShares Morningstar Mid-Cap Growth ETF in Q1 2016 and has held it in 29 quarters since.
  • 423 funds tracked by Wall St. Rank held iShares Morningstar Mid-Cap Growth ETF as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.